{"cluster": 69, "subcluster": 50, "abstract_summ": "CONCLUSIONS: The changes in the whole health care system during the COVID\u201019 pandemic have impacted the management of patients with head and neck cancer, generating several clinical challenges for the ENT surgeon.INTRODUCTION: For the EARs NOSE AND THROAT (ENT) surgeon, there are many challenges that show\u2010up in the clinical management of a patient affected by a head and neck cancer during COVID\u201019 pandemic, especially in the postoperative period.CONCLUSIONS: The COVID\u201019 pandemic has caused a reduction in HNC care.Rapid COVID\u201019 testing and correlation with infectious potential remain paramount to resuming the care of patients with head and neck cancer.In penile cancer with low risk of progression, surgical treatment can be delayed, but other options must be considered, like topical treatment or laser therapy.", "title_summ": "Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS\u2010CoV\u20102 (COVID19) pandemicClinical and surgical management of patients with head and neck cancer in a COVID\u201019 dedicated center in ItalyTherapeutic and Surgical Indications for Patients with Penile Cancer in the COVID-19 era.Radical change in osteosarcoma surgical plan due to COVID-19 pandemic.", "title_abstract_phrases": "Clinical and surgical management of patients with head and neck cancer in a COVID\u201019 dedicated center in ItalyINTRODUCTION: For the EARs NOSE AND THROAT (ENT) surgeon, there are many challenges that show\u2010up in the clinical management of a patient affected by a head and neck cancer during COVID\u201019 pandemic, especially in the postoperative period.CONCLUSIONS: The changes in the whole health care system during the COVID\u201019 pandemic have impacted the management of patients with head and neck cancer, generating several clinical challenges for the ENT surgeon.Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS\u2010CoV\u20102 (COVID19) pandemicBACKGROUND: The SARS\u2010CoV\u20102 (COVID\u201019) pandemic has caused rapid changes in head and neck cancer (HNC) care.Rapid COVID\u201019 testing and correlation with infectious potential remain paramount to resuming the care of patients with head and neck cancer.Therapeutic and Surgical Indications for Patients with Penile Cancer in the COVID-19 era."}